ANALYSIS OF DISEASES ACCOMPANYING MYOCARDIAL INFARCTION
COVID-19 infection has become a major concern for the medical community. Various studies have shown that COVID-19 disruptions in the immune system, increased metabolic demand, and procoagulant activity caused by coronavirus can lead to adverse outcomes in the population with cardiovascular diseases [1, 2, 3,4].
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2024-12-12
- DOI
- https://doi.org/10.5281/zenodo.14414615
- Primary Topic
- Genetic diversity and population structure
- Type
- article
- Field-Weighted Citation Impact
- 0.00